There are 2 item(s) tagged with the keyword "Cancer".
Displaying: 1 - 2 of 2
Last week, 120 employers and industry leaders came together in Washington, DC for the NBGH Employers’ Summit on Health Care Costs & Solutions. Attendees had the opportunity to hear from Dr. Kathryn Phillips, founder and director of the UCSF Center for Translational and Policy Research on Personalized Medicine regarding the evolving landscape of genetic tests and treatments and the ways to evaluate their economic value.
In recent years, major breakthrough cancer therapies have entered onto the oncology stage, namely actors in immunotherapy that have shown extraordinary promise. These new agents differ from conventional treatments in that they selectively target aspects of the immune system to optimize the innate response to invading cancer cells.
Displaying: 1 - 2 of 2